PE 100 mg infused for 2 h with 10 mg given as a bolus Longer duration a This period can be extended to 4.5 hours unless any of the following exclusion criteria are present: patients older than 80 years, patients taking oral anticoagulants regardless of the international normalized ratio, patients with baseline NIHSS score higher than 25, and patients with a history of stroke and diabetes. b For...

Single photon emission computed tomography (SPECT) with technetium-99m hexakis 2-methoxyisobutyl isonitrile was investigated as a method to evaluate the results of intravenous thrombolytic treatment in 14 patients (11 men and 3 women) with acute myocardial infarction admitted to the coronary care unit within 4 h of the onset of symptoms. All patients received an injection of 740 MBq of the trac...

AIMS To assess the efficacy and safety of bone marrow cell (BMC) therapy after thrombolytic therapy of an acute ST-elevation myocardial infarction (STEMI). METHODS AND RESULTS Patients with STEMI treated with thrombolysis followed by percutaneous coronary intervention (PCI) 2-6 days after STEMI were randomly assigned to receive intracoronary BMCs (n = 40) or placebo medium (n = 40), collected...

OBJECTIVE Between July 1992 and December 1994, 16 French hospital centres, mainly cardiological, participated in a non-controlled observational study on venous thromboembolic disease. The objective of this survey was to collect data concerning the current status of pulmonary embolism and deep venous thrombosis. PATIENTS During this period, 547 patients were included: 446 with deep venous thro...

Objectives: To determine the outcome of thrombolysis in patients with Prosthetic valve thrombosis (PVT). Design : A retrospective descriptive study. Setting : The intensive care unit of the National Cardiothoracic centre, Korle-bu Teaching Hospital , Accra, Ghana. Subjects: 5 consecutive patients who were thrombolysed for 6 episodes of prosthetic valve thrombosis. Method: Over a 3-year period 5...

Portal vein thrombosis may occur in the presence or absence of underlying liver disease, and a combination of local and systemic factors are increasingly recognized to be important in its development. Acute and chronic portal vein thrombosis have traditionally been considered separately, although a clear clinical distinction may be difficult. Gastrooesophageal varices are an important complicat...

Neonatal thromboembolism occurs with various predispositions and triggers. Early diagnosis of the thrombosis is challenging and essential for the therapeutic interventions. We herein report two newborns who presented with transient hemi-lower limb ischemia due to (1) arterial thrombosis or (2) a persistent sciatic artery (PSA). The patient with arterial thrombosis showed elevations of fibrin de...

The risk of venous thromboembolic complications among pregnant women and puerperas is higher than in the general population, which due to traditional factors, as well physiological anatomical changes that occur during pregnancy. Symptoms signs pregnancy are often nonspecific may coincide with consequences changes, including dyspnea, limb edema, tachycardia. D-dimer levels be elevated ongoing pr...

1. Chawla Y, Duseja A, Dhiman RK. Review article: The modern management of portal vein thrombosis. Aliment Pharmacol Ther 2009;30:881-94. 2. Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Maurizio L, et al. Portal vein thrombosis: Insight into physiopathology, diagnosis and treatment. World J Gastroenterol 2010; 16:143-55. 3. Distefano G, Rodono A, Cilauro S, Saporito A, Pennisi F...

been widely accepted as an effective method to treat acute deep vein thrombosis of the lower extremities (13). Vascular access through the popliteal vein is the most common route for the procedure. To date, procedure-related complications such as hemorrhaging, pulmonary embolism, infection and, sepsis have been reported. However, to our knowledge, iatrogenic arteriovenous fistulas have not been...